On May 2, 2022, POLITICO reported it had received a leaked draft of the United States Supreme Court’s forthcoming opinion in Dobbs v. Jackson Women’s Health Organization, in which the Court purportedly plans to overturn Roe v. Wade and Planned Parenthood of Southeast Pennsylvania v. Casey, two of the seminal cases serving as the foundation of women’s reproductive health rights for the last 50 years.

The decision has the very real potential to turn the world upside down for many health care entities, from providers and pharmacies to manufacturers and payers. Reed Smith’s Reproductive Health Working Group is closely following developments in this space to address these issues for any client in the industry.In our first installment of “Unanswered Questions,” we explore the potential implications of the Dobbs opinion for pharmacies.

To view the full report, please download the PDF from the link below.